Correlation Between SynCore Biotechnology and Asia Vital

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SynCore Biotechnology and Asia Vital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SynCore Biotechnology and Asia Vital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SynCore Biotechnology Co and Asia Vital Components, you can compare the effects of market volatilities on SynCore Biotechnology and Asia Vital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SynCore Biotechnology with a short position of Asia Vital. Check out your portfolio center. Please also check ongoing floating volatility patterns of SynCore Biotechnology and Asia Vital.

Diversification Opportunities for SynCore Biotechnology and Asia Vital

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between SynCore and Asia is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding SynCore Biotechnology Co and Asia Vital Components in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Asia Vital Components and SynCore Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SynCore Biotechnology Co are associated (or correlated) with Asia Vital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Asia Vital Components has no effect on the direction of SynCore Biotechnology i.e., SynCore Biotechnology and Asia Vital go up and down completely randomly.

Pair Corralation between SynCore Biotechnology and Asia Vital

Assuming the 90 days trading horizon SynCore Biotechnology Co is expected to under-perform the Asia Vital. But the stock apears to be less risky and, when comparing its historical volatility, SynCore Biotechnology Co is 1.83 times less risky than Asia Vital. The stock trades about -0.11 of its potential returns per unit of risk. The Asia Vital Components is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  58,100  in Asia Vital Components on August 26, 2024 and sell it today you would earn a total of  7,100  from holding Asia Vital Components or generate 12.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

SynCore Biotechnology Co  vs.  Asia Vital Components

 Performance 
       Timeline  
SynCore Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Asia Vital Components 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Asia Vital Components are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Asia Vital may actually be approaching a critical reversion point that can send shares even higher in December 2024.

SynCore Biotechnology and Asia Vital Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SynCore Biotechnology and Asia Vital

The main advantage of trading using opposite SynCore Biotechnology and Asia Vital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SynCore Biotechnology position performs unexpectedly, Asia Vital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Asia Vital will offset losses from the drop in Asia Vital's long position.
The idea behind SynCore Biotechnology Co and Asia Vital Components pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.